Using an Advanced Practice Pharmacist in a Team-Based Care Model to Decrease Time to Hemoglobin A(1c) Goal Among Patients With Type 2 Diabetes, Florida, 2017–2019

Collaborative practice models that use an advanced practice pharmacist (APP) have been shown to improve outcomes for patients with chronic diseases. Few studies have evaluated the effects of team-based practice models involving an APP for time needed to attain glycated hemoglobin A(1c) (HbA(1c)) goa...

Descripción completa

Detalles Bibliográficos
Autores principales: Cowart, Kevin, Updike, Wendy, Emechebe, Nnadozie, Zgibor, Janice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2020
Materias:
Brief
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279065/
https://www.ncbi.nlm.nih.gov/pubmed/32498760
http://dx.doi.org/10.5888/pcd17.190377
Descripción
Sumario:Collaborative practice models that use an advanced practice pharmacist (APP) have been shown to improve outcomes for patients with chronic diseases. Few studies have evaluated the effects of team-based practice models involving an APP for time needed to attain glycated hemoglobin A(1c) (HbA(1c)) goals in patients with diabetes mellitus (type 2 diabetes). Ours is a retrospective cohort study, involving patients with type 2 diabetes who worked with a pharmacist in an academic family medicine clinic. These patients experienced a shorter time to achieve an HbA(1c) of less than 7%, as compared with patients who did not work with a pharmacist. Future studies should evaluate the length of time patients can sustain an HbA(1c) of less than 7% with team-based care involving an APP and the influence of such care on diabetes-related complications.

Ejemplares similares